Cationic Amphiphilic Polymers for Specialized Therapeutic Delivery

A novel formulation of cationic amphiphilic polymers adapted for delivery of therapeutic compounds in extreme weather conditions, high-security needs, disaster relief, and unique operational environments.

The original patent disclosed cationic amphiphilic polymers for co-delivery of hydrophobic agents and nucleic acids, but it did not address the challenges of delivering therapeutic compounds in specialized environments. The new inventive concept addresses this limitation by adapting the polymers for use in extreme weather conditions, high-security needs, disaster relief, and unique operational environments, ensuring effective delivery of therapeutic compounds in these challenging situations.

The new inventive concept comprises a formulation of cationic amphiphilic polymers with a hydrophobic polymer backbone formed via radical polymerization, and pendant groups attached to the backbone. The polymers are adapted to withstand extreme weather conditions, such as high winds and heavy rainfall, and high-security needs, such as being undetectable by security scanners. The formulation is designed to deliver therapeutic compounds, including small molecule therapeutic compounds with a molecular weight below 1 kDa, RNA or DNA, and genes or siRNA, in a variety of operational environments, including disaster relief, extreme cold, and high-altitude environments.

The new claims introduce novel adaptations of the original polymer formulation to address specific challenges in specialized environments, including extreme weather conditions, high-security needs, disaster relief, and unique operational environments. The inventive step lies in the tailored design of the polymers to withstand these challenging conditions, ensuring effective delivery of therapeutic compounds.

Alternative embodiments of the inventive concept could include adaptations for use in other specialized environments, such as space exploration or underwater operations. Variations of the polymers could include different pendant groups or backbone structures to optimize delivery in specific environments.

The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in areas such as disaster relief, high-security needs, and extreme environment operations. The market for specialized therapeutic delivery systems is growing, and this inventive concept is well-positioned to capture a significant share of this market.